Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17577624rdf:typepubmed:Citationlld:pubmed
pubmed-article:17577624lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0879262lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:17577624lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17577624pubmed:issue2lld:pubmed
pubmed-article:17577624pubmed:dateCreated2007-6-19lld:pubmed
pubmed-article:17577624pubmed:abstractTextS-1 is an oral fluoropyrimidine that promises better and accessible treatment. This article identifies the risk factors for severe adverse events of S-1 from nationwide survey data.lld:pubmed
pubmed-article:17577624pubmed:languageenglld:pubmed
pubmed-article:17577624pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:citationSubsetIMlld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17577624pubmed:statusMEDLINElld:pubmed
pubmed-article:17577624pubmed:issn1436-3291lld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:YamanakaTakeh...lld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:TeramukaiSato...lld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:NagaiYojiYlld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:FukushimaMasa...lld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:IshiwataRyota...lld:pubmed
pubmed-article:17577624pubmed:authorpubmed-author:MatsumotoShig...lld:pubmed
pubmed-article:17577624pubmed:issnTypePrintlld:pubmed
pubmed-article:17577624pubmed:volume10lld:pubmed
pubmed-article:17577624pubmed:ownerNLMlld:pubmed
pubmed-article:17577624pubmed:authorsCompleteYlld:pubmed
pubmed-article:17577624pubmed:pagination129-34lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:meshHeadingpubmed-meshheading:17577624...lld:pubmed
pubmed-article:17577624pubmed:year2007lld:pubmed
pubmed-article:17577624pubmed:articleTitleAnalysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.lld:pubmed
pubmed-article:17577624pubmed:affiliationCancer Biostatics Laboratory, Institute for Clinical Research, National Kyushu Cancer Center, 3-1-1 Notame, Fukuoka, Japan.lld:pubmed
pubmed-article:17577624pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17577624lld:pubmed